Thompson, P. A., Srivastava, J., Peterson, C., Strati, P., Jorgensen, J. L., Hether, T., . . . Wierda, W. G. (2019). Minimal residual disease undetectable by next-generation sequencing predicts improved outcome in CLL after chemoimmunotherapy. Blood.
Citação norma ChicagoThompson, Philip A., et al. "Minimal Residual Disease Undetectable By Next-generation Sequencing Predicts Improved Outcome in CLL After Chemoimmunotherapy." Blood 2019.
Citação norma MLAThompson, Philip A., et al. "Minimal Residual Disease Undetectable By Next-generation Sequencing Predicts Improved Outcome in CLL After Chemoimmunotherapy." Blood 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.